SG11202003539VA - Compositions and methods for treating liberibacter diseases and other bacterial diseases - Google Patents
Compositions and methods for treating liberibacter diseases and other bacterial diseasesInfo
- Publication number
- SG11202003539VA SG11202003539VA SG11202003539VA SG11202003539VA SG11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA
- Authority
- SG
- Singapore
- Prior art keywords
- diseases
- liberibacter
- compositions
- treating
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Virology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762575993P | 2017-10-23 | 2017-10-23 | |
US201862677817P | 2018-05-30 | 2018-05-30 | |
PCT/US2018/057153 WO2019084040A1 (en) | 2017-10-23 | 2018-10-23 | Compositions and methods for treating liberibacter diseases and other bacterial diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202003539VA true SG11202003539VA (en) | 2020-05-28 |
Family
ID=66247003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202003539VA SG11202003539VA (en) | 2017-10-23 | 2018-10-23 | Compositions and methods for treating liberibacter diseases and other bacterial diseases |
Country Status (7)
Country | Link |
---|---|
US (2) | US11963533B2 (en) |
EP (1) | EP3700547A4 (en) |
CN (1) | CN111246875B (en) |
BR (1) | BR112020007108A2 (en) |
MX (1) | MX2020004118A (en) |
SG (1) | SG11202003539VA (en) |
WO (1) | WO2019084040A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2022004320A (en) * | 2019-10-11 | 2022-05-11 | Univ California | Compositions and methods for treating liberibacter diseases and other bacterial diseases. |
US11518694B2 (en) * | 2019-12-18 | 2022-12-06 | Maxwell Zachary Price | Methods of inhibiting cyanobacteria using citron |
CN111748555A (en) * | 2020-07-22 | 2020-10-09 | 西南大学 | sgRNA for improving citrus and application and use method thereof |
WO2022174232A2 (en) * | 2021-02-09 | 2022-08-18 | The Regents Of The University Of California | Immune regulators involved in defense against plant diseases caused by liberibacter species |
CN114350702A (en) * | 2022-01-27 | 2022-04-15 | 浙江农林大学 | Virus inoculation method for citrus |
CN116715733A (en) * | 2022-10-18 | 2023-09-08 | 深圳润康生态环境股份有限公司 | Antibacterial peptide STJ-2 for effectively inhibiting proliferation of citrus yellow dragon disease pathogenic bacteria and application thereof |
CN118666972A (en) * | 2023-03-14 | 2024-09-20 | 中国科学院微生物研究所 | Antibacterial peptide and application thereof in preventing and treating citrus yellow dragon disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2806731A4 (en) | 2012-01-27 | 2015-09-23 | Texas A & M Univ Sys | Pathogen resistant citrus compositions, organisms, systems, and methods |
MX2013004623A (en) * | 2013-04-24 | 2014-10-24 | Ct Investig Y Estudios Del Ipn | Methods for obtaining genetically modified plants resistant to pathogenic microorganisms growing in vascular tissues. |
WO2017011815A2 (en) * | 2015-07-15 | 2017-01-19 | Texas A&M University | Citrus plants resistant to citrus huanglongbing (ex greening) caused by candidatus liberibacter asiaticus (las) and bacterial canker caused by (xanthomonas axonopodis pv. citri) (xac) using spinach defensin genes in ctv vectors |
WO2017011796A1 (en) * | 2015-07-15 | 2017-01-19 | The Texas A&M University System | Pathogen resistant citrus compositions, organisms, systems, and methods |
CN106337059A (en) * | 2016-09-12 | 2017-01-18 | 西南大学 | Method for improving citrus huanglongbing resistance |
-
2018
- 2018-10-23 MX MX2020004118A patent/MX2020004118A/en unknown
- 2018-10-23 SG SG11202003539VA patent/SG11202003539VA/en unknown
- 2018-10-23 EP EP18870019.9A patent/EP3700547A4/en active Pending
- 2018-10-23 CN CN201880068474.6A patent/CN111246875B/en active Active
- 2018-10-23 WO PCT/US2018/057153 patent/WO2019084040A1/en unknown
- 2018-10-23 US US16/757,284 patent/US11963533B2/en active Active
- 2018-10-23 BR BR112020007108-0A patent/BR112020007108A2/en unknown
-
2024
- 2024-03-19 US US18/609,859 patent/US20240306649A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3700547A4 (en) | 2021-10-27 |
MX2020004118A (en) | 2020-07-29 |
US20210186028A1 (en) | 2021-06-24 |
US11963533B2 (en) | 2024-04-23 |
WO2019084040A1 (en) | 2019-05-02 |
EP3700547A1 (en) | 2020-09-02 |
BR112020007108A2 (en) | 2020-10-13 |
CN111246875A (en) | 2020-06-05 |
US20240306649A1 (en) | 2024-09-19 |
CN111246875B (en) | 2024-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3634442A4 (en) | Methods for treating and preventing diseases | |
IL273959A (en) | Methods and compositions for the treatment of rare diseases | |
SG11202003539VA (en) | Compositions and methods for treating liberibacter diseases and other bacterial diseases | |
EP3319976A4 (en) | Compositions and methods for treating lung diseases and lung injury | |
EP3826666A4 (en) | Compositions and methods for treating nrp2-associated diseases | |
AU2018297285A1 (en) | Compositions and methods for treating or preventing endocrine FGF-linked diseases | |
IL269158A (en) | Compositions and methods for treating inflammatory diseases | |
IL274702A (en) | Compositions and methods for neurological diseases | |
EP3139928A4 (en) | Anordrin compositions and methods for treating diseases | |
EP3310385A4 (en) | Methods and compositions for treating fibrotic diseases | |
EP3110446A4 (en) | Methods and compositions for treating siglec-8 associated diseases | |
IL280413A (en) | Bismuth-thiol compositions and methods for treating wounds | |
EP3268010A4 (en) | Compositions and methods for treating bacterial infection | |
EP3634431A4 (en) | Therapeutic compositions and methods for treating hepatitis b | |
IL275767A (en) | Compositions and methods for treating metabolic diseases | |
EP3634422A4 (en) | Methods of treating leukodystrophies | |
EP3600291A4 (en) | Compositions and methods for treating synucleinopathies | |
EP3190893A4 (en) | Compositions and methods for treating and preventing bacterial infections | |
EP3411367A4 (en) | Compositions and methods for treating infections | |
EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
DK3630111T3 (en) | Compounds and methods for treating bacterial infections | |
EP3823593A4 (en) | Compositions and methods for treating autism | |
PL3810128T3 (en) | Compositions for treating and/or preventing protein-aggregation diseases | |
EP3672583A4 (en) | Compositions and methods for treating neurodegenerative diseases | |
EP3658118A4 (en) | Methods and compositions for treating respiratory disease |